European Academy of Neurology
Our mission is to promote neurological excellence in Europe and across the world, leading to better patient care and outcomes. We unite 47 national societies and represent more than 45,000 neurologists to achieve this goal.
Find out more.
MyEAN
your home of neurology.
Register for the congress, manage your membership and more.
Login/ RegisterEAN pages: Latest posts
- Assessing brain capillaries in coronavirus disease 2019
- Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021
- Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection. The COVID A to Z randomized clinical trial
- Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial
- Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
European Journal of Neurology
Free for EAN members
Read the online version of the European Journal of Neurology here.
European Academy of Neurology
EAN Priorities 2020-2024
Vision: Be the Home of Neurology and advance high-quality patient care
Mission: Reduce the burden of neurological diseases
|
Dementia and cognitive disorders